Riskpilot← Back to searchSign inGet full accesselmym AB
ABIn liquidationOrg 5567418149Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20070 employees
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK 0
+100% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | — | — |
| Net profit | SEK 0 | +100% |
| Total assets | SEK 25K | +39% |
| Equity | SEK 25K | +39% |
| Employees | 0 | — |
Legal name
elmym AB
Org number
5567418149
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1 november 2007
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-04-30
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall bedriva import och handel med hygienprodukter, främst handdesinfektionsmedel och därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −1 | — | −3 | −8 799 | — |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −1 | 0 | −3 | −8 799 | 0 |
| Net financials | — | — | −3 | — | — |
| Profit before tax | −1 | 0 | −6 | −8 799 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −1 | 0 | −6 | −8 799 | 0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 10 478 | 10 478 | 10 472 | 18 | 25 |
| Equity | 8 823 | 8 823 | 8 817 | 18 | 25 |
| Long-term debt | 1 270 | 1 270 | 1 270 | 0 | 0 |
| Short-term debt | 385 | 385 | 385 | 0 | 0 |
| Total debt | 1 655 | 1 655 | 1 655 | — | — |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-05-01 – 2020-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KS Liquidator | Liquidator | 2022 |
| Former (1) | ||
PS Chief Executive Officer | Chief Executive Officer | 2023 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Deputy Board Member | 2023 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of elmym AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Stefan Mattsson | Liquidator | 0 companies |
| Patrik Sjöö | Chief Executive Officer | 0 companies |
| Cecilia Sjöö | Deputy Board Member | 0 companies |